HBK Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,200
Closed -$636K 285
2023
Q2
$636K Buy
+9,200
New +$655K ﹤0.01% 313
2022
Q3
Sell
-53,900
Closed -$4.99M 451
2022
Q2
$4.99M Sell
53,900
-2,900
-5% -$283K 0.03% 217
2022
Q1
$5.75M Buy
+56,800
New +$5.97M 0.02% 235
2021
Q4
Sell
-106,500
Closed -$9.04M 742
2021
Q3
$9.04M Buy
106,500
+42,400
+66% +$3.55M 0.04% 135
2021
Q2
$5.35M Buy
+64,100
New +$5.25M 0.02% 281
2021
Q1
Sell
-121,500
Closed -$8.3M 889
2020
Q4
$8.3M Sell
121,500
-41,400
-25% -$2.69M 0.05% 153
2020
Q3
$9.51M Sell
162,900
-9,600
-6% -$597K 0.07% 117
2020
Q2
$11.2M Buy
+172,500
New +$10.9M 0.15% 77
2020
Q1
Sell
-316,500
Closed -$23.5M 142
2019
Q4
$23.5M Buy
316,500
+139,000
+78% +$9.76M 0.23% 37
2019
Q3
$11.2M Sell
177,500
-102,700
-37% -$6.09M 0.14% 102
2019
Q2
$15.3M Buy
+280,200
New +$15.1M 0.13% 66

Other funds holding CVS

HBK Investments's CVS Position: Q3 2022 in Review

HBK Investments sold out of CVS Health (CVS) in Q3 2022, closing a stake of 4,079 shares — an estimated $378K sold.

HBK Investments first reported a position in CVS in Q3 2013 and held it in 12 quarters. The position peaked at $8.36M in Q3 2020. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • HBK Investments reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • HBK Investments sold 4,079 CVS Health shares in Q3 2022, an estimated $378K.
  • HBK Investments first reported a position in CVS Health in Q3 2013 and held it in 12 quarters.
  • HBK Investments's CVS Health position peaked at $8.36M in Q3 2020.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.